RPL22L1 and ovarian cancer: Our team previously identified 3q26.2 as an origin of DMs in the human ovarian cancer cell line UACC-1598, and a series of genes were co-amplified on the same ovarian DMs, including MYCN, EIF5A2, and RPL22L1 [13].